NLRP3 and metabolic disease: We subsequently found that sEVs derived from steatotic liver promote NLRP3 inflammasome-dependent microvascular endothelial hyperpermeability, suggested that hepatic sEVs might be an independent pathogenic factor of CMD independent from the metabolic disorders during NAFLD.